SOURCES:
Colleen Krejewski, MD, assistant professor of Obstetrics, Gynecology, and Reproductive Sciences, College of Pittsburgh.
Sheila Chhutani, MD, OB-GYN, Texas Well being Presbyterian Hospital Dallas.
Richard Kaye, MD, OB-GYN, Texas Well being Presbyterian Hospital Plano.
American Congress of Obstetricians and Gynecologists, Committee Opinion: “Threat of Venous Thromboembolism Amongst Customers of Drospirenone-Containing Oral Contraceptive Capsules.”
Facilities for Illness Management: Abstract Chart of U.S. Medical Eligibility Standards for Contraceptive Use.
FamilyDoctor.org: Progestin-Solely Contraceptives.
Nationwide Most cancers Institute: Oral Contraception and Most cancers Threat.
Marchbanks, PA, Contraception, April 2012.
Bedsider.org: “What’s the Threat?”
FDA.gov: Depo-Provera Contraceptive injection (medroxyprogesterone acetate) injectable suspension
Berenson, A, American Journal of Obstetrics & Gynecology, March, 2009
American Congress of Obstetricians and Gynecologists, Committee Opinion: “Depot Medroxyprogesterone Acetate and Bone Results”
Deliberate Parenthood: “IUD,” “When does an IUD begin working?”
Affiliation of Reproductive Well being Professionals: “Well being Issues Reality Sheets: Copper T IUD,” “Non-hormonal Contraceptive Strategies,” “Strategies Match.”
